Lushang Freda Pharmaceutical Co., Ltd. Class A
SHH: 600223.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Real Estate
- Industry
- Real Estate - Development
- CEO
- Baiqiang Xu
- Employees
- 3,630
- Headquarters
- Jinan, China
- IPO year
- 2000
- Market cap
- CN¥7.0B
- Website
- https://www.lshfreda.com
Loading 600223…
Loading profile data…Frequently asked questions about 600223
What does Lushang Freda Pharmaceutical Co., Ltd. Class A (600223.SS) do?
Lushang Health Industry Development Co.,Ltd. develops and operates real estate properties in China. It develops residences, commercial complexes, shopping malls, high-end office buildings, star hotels, and other projects. The company was formerly known as Lushang Property Co., Ltd. and changed its name to Lushang Health Industry Development Co.,...
Where does 600223.SS trade?
Lushang Freda Pharmaceutical Co., Ltd. Class A (600223.SS) trades on the Shanghai Stock Exchange.
What sector is 600223.SS in?
Lushang Freda Pharmaceutical Co., Ltd. Class A (600223.SS) operates in the Real Estate sector, specifically in the Real Estate - Development industry.
Who is the CEO of Lushang Freda Pharmaceutical Co., Ltd. Class A?
Baiqiang Xu is the chief executive officer of Lushang Freda Pharmaceutical Co., Ltd. Class A (600223.SS).
Where is Lushang Freda Pharmaceutical Co., Ltd. Class A headquartered?
Lushang Freda Pharmaceutical Co., Ltd. Class A is headquartered in China.
Does 600223.SS pay a dividend?
Yes — Lushang Freda Pharmaceutical Co., Ltd. Class A (600223.SS) paid a trailing twelve-month dividend of CNY 0.06 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600223.SS go public?
Lushang Freda Pharmaceutical Co., Ltd. Class A (600223.SS) completed its initial public offering in 2000.